Ann: First Competitive Read Out - Peptide Vaccine, page-22

According to Telethon Kids' web site as of today, PYC is still listed as a researcher under contract.

https://www.telethonkids.org.au/our-research/chronic-and-severe-diseases/cancer/drug-discovery-unit/

The research of the unit is funded by contracts with several large pharmaceutical companies via a commercial entity named “Phylogica”, which was the first spin-off company from the Telethon Kids Institute. Listed on the Australian Stock Exchange, Phylogica (PYC) is a specialist drug discovery company that identifies new prototype drugs for pharmaceutical partners. In the last few years, Phylogica has entered into alliances with several of the leading global Pharmaceutical companies, including Roche, Pfizer, Medimmune (AstraZeneca), Janssen (Johnson and Johnson) and Genentech (a subsidiary of Roche).